MET and cancer: MET is an RTK for hepatocyte growth factor (HGF), which plays key roles in transducing signals that lead to increased cancer cell invasion and metastasis, and much signalling downstream of MET is thought to be mediated via activation of the oncogene activator of transcription, STAT3.